Literature DB >> 6805553

Gastric carcinoma and thrombotic thrombocytopenic purpura: association with plasma immune complex concentrations.

S E Zimmerman, F P Smith, T M Phillips, R J Coffey, P S Schein.   

Abstract

A patient with metastatic adenocarcinoma of the stomach developed microangiopathic haemolytic anaemia, thrombocytopenia, renal insufficiency, and fluctuating neurological abnormalities in association with appreciably raised plasma concentrations of immune complexes. This syndrome, similar to thrombotic thrombocytopenic purpura, occurred while the tumour was in sustained objective remission after successful treatment with fluorouracil, doxorubicin, and mitomycin. Reversal of the syndrome was achieved with plasmapheresis, azathioprine, corticosteroids, and antiplatelet treatment; this response was paralleled by a reduction in immune complex concentration, suggesting an immune aetiology for the syndrome. Antibodies eluted from the immune complexes reacted with 50% of cells from the gastric cancer but less than 10% of cells from normal gastric mucosa. There was no reactivity with either carcinoembryonic antigen or mitomycin. A 17S immune complex reacted with a glycoprotein from the patient's autologous platelets and produced platelet aggregation. It is postulated that reducing the tumour and the pre-existing state of antigen excess by chemotherapy allowed soluble antigen-antibody complexes to form and the syndrome to develop.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805553      PMCID: PMC1498348          DOI: 10.1136/bmj.284.6327.1432

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  27 in total

1.  THROMBOTIC THROMBOCYTOPENIC PURPURA AND SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  S LEVINE; M A SHEARN
Journal:  Arch Intern Med       Date:  1964-06

2.  Immunological studies in nephrotic syndrome associated with extrarenal malignant disease.

Authors:  M G Lewis; L W Loughridge; T M Phillips
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

3.  Role of complement and leukocytes in immunologic release of vasoactive amines from platelets.

Authors:  P M Henson
Journal:  Fed Proc       Date:  1969 Sep-Oct

4.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

5.  A system of immunofluorescence in the study of tumour cells.

Authors:  T M Phillips; M G Lewis
Journal:  Rev Eur Etud Clin Biol       Date:  1970-11

6.  Renal toxicity in man treated with mitomycin C.

Authors:  K Liu; A Mittelman; E E Sproul; E G Elias
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

7.  Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma.

Authors:  M C Brain; J G Azzopardi; L R Baker; G F Pineo; P D Roberts; J V Dacie
Journal:  Br J Haematol       Date:  1970-02       Impact factor: 6.998

8.  Platelet aggregation and release of ADP, serotonin and histamine associated with phagocytosis of antigen-antibody complexes.

Authors:  H Z Movat; J F Mustard; N S Taichman; T Uriuhara
Journal:  Proc Soc Exp Biol Med       Date:  1965-10

9.  Thrombotic thrombocytopenic purpura: report of a case with possible immune etiology.

Authors:  M J Mant; M N Cauchi; G Medley
Journal:  Blood       Date:  1972-09       Impact factor: 22.113

10.  Antigen-antibody reaction in the pathogenesis of bilateral renal cortical necrosis.

Authors:  L LEE
Journal:  J Exp Med       Date:  1963-03-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.